ALB and cancer: In addition to these inflammatory biomarkers, the PNI, a simple and inexpensive immunonutritional index developed by Onodera et al., is a marker that evaluates the nutritional status with the albumin in its formulation and the immune status with the absolute lymphocyte count, and has been shown to be an independent prognostic factor in many cancer types [7–9, 11–13, 20–22].